Lancer Orthodontics, Inc. (LANZ) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 4.00 means the share price is 4.00 times one year of earnings per share; the S&P 500 usually sits near 20-25.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerLancer Orthodontics, Inc. (LANZ) trades at $0.04. Lancer Orthodontics, Inc. designs, manufactures, and markets orthodontic products for orthodontists and dentists globally. The company offers a comprehensive range of orthodontic supplies, including brackets, adhesives, and instruments. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for LANZ: LANZ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LANZ against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
LANZ: the 2 scored disciplines are evenly split. Dominant signal: Izzy Englander bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Lancer Orthodontics, Inc. (LANZ) Healthcare & Pipeline Overview
Lancer Orthodontics, Inc., founded in 1967, provides a comprehensive suite of orthodontic products to dental professionals worldwide. With a focus on brackets, adhesives, and instruments, the company serves a global market, maintaining a niche position within the broader medical instruments and supplies sector, evidenced by its P/E ratio of 4.00 and 0.5% profit margin.
What Is the Investment Thesis for LANZ?
Lancer Orthodontics, Inc. presents a focused investment case centered on its established position in the orthodontic supplies market. The company’s comprehensive product range and long-standing history since 1967 provide a stable foundation. Key value drivers include maintaining its existing customer base and potentially expanding its product offerings. A P/E ratio of 4.00 suggests possible undervaluation relative to earnings, though the low 0.5% profit margin warrants careful consideration. Growth catalysts involve expanding into new geographic markets or introducing innovative products. Potential risks include competition from larger players in the medical instruments and supplies sector and the challenges of navigating the OTC market. Investors should carefully assess the company's financial performance, growth strategies, and risk factors before making any investment decisions.
Based on FMP financials and quantitative analysis
LANZ Key Highlights
Lancer Orthodontics, Inc. was founded in 1967, demonstrating a long-standing presence in the orthodontic supplies market.
- The company offers a comprehensive range of orthodontic products, including brackets, adhesives, wires, and instruments.
- Lancer Orthodontics serves a global market, catering to orthodontists and dentists worldwide.
- The company's P/E ratio is 4.00, which may indicate potential undervaluation.
- The company's gross margin is 31.5%.
Who Are LANZ's Competitors?
LANZ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| LUCY Innovative Eyewear, Inc. | $0.84 | -3.05% | $5.31M | — |
| FEMY Femasys Inc. | $2.74 | -3.18% | $8.27M | — |
| RGNT Regentis Biomaterials Ltd. | $1.89 | -3.57% | $13.3M | 645-pillar |
| ZJYL Jin Medical International Ltd. | $2.06 | -8.44% | $16.1M | 405-pillar |
| HBIO Harvard Bioscience, Inc. | $8.16 | +0.12% | $36.8M | — |
| MLSS Milestone Scientific Inc. | $0.43 | +3.85% | $38.4M | — |
| POCI Precision Optics Corporation, Inc. | $4.45 | +1.37% | $48.7M | 325-pillar |
| NEPH Nephros, Inc. | $4.52 | 0.00% | $49.1M | 335-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LANZ's Key Strengths?
Long-standing presence in the market since 1967.
- Comprehensive product range covering various orthodontic needs.
- Global customer base providing revenue diversification.
- Specialized focus on orthodontics, allowing for deep expertise.
What Are LANZ's Weaknesses?
Small market capitalization of $0.00B, limiting access to capital.
- Low profit margin of 0.5%, indicating potential operational inefficiencies.
- OTC market listing, which may deter some institutional investors.
- Limited brand recognition compared to larger competitors.
What Could Drive LANZ Stock Higher?
Potential expansion into new geographic markets, such as Asia-Pacific and Latin America.
- Introduction of innovative orthodontic products, such as advanced bracket systems and digital solutions.
- Strategic partnerships with dental clinics, universities, and research institutions.
- Enhanced digital marketing and e-commerce presence to reach a wider audience.
- Focus on value-added services and training programs for orthodontists and dentists.
What Are the Key Risks for LANZ?
Financial-distress signal — its Altman Z-Score of 1.78 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Competition from larger, more established medical device companies.
- Stringent regulatory requirements and compliance costs.
- Economic downturns affecting consumer spending on elective orthodontic procedures.
- Technological advancements rendering existing products obsolete.
- Risks associated with trading on the OTC market, including limited liquidity and disclosure.
What Are the Growth Opportunities for LANZ?
- Expansion into Emerging Markets: Lancer Orthodontics can pursue growth by expanding its presence in emerging markets, particularly in Asia-Pacific and Latin America. These regions are experiencing rapid economic growth and increasing demand for orthodontic treatments. By establishing distribution partnerships and tailoring its product offerings to meet local needs, Lancer Orthodontics can tap into these high-growth markets.
- Product Innovation and Development: Investing in research and development to introduce innovative orthodontic products can drive growth. This includes developing advanced bracket systems, biocompatible materials, and digital solutions for treatment planning and monitoring. By staying at the forefront of technological advancements, Lancer Orthodontics can attract new customers and gain a competitive edge. The market for advanced orthodontic materials is expected to grow substantially over the next five years.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with dental clinics, universities, and research institutions can enhance Lancer Orthodontics' market reach and product development capabilities. Acquiring smaller orthodontic suppliers can also expand the company's product portfolio and customer base. These partnerships can provide access to new technologies, distribution channels, and market insights. The mergers and acquisitions activity in the medical device industry remains robust, presenting opportunities for strategic growth.
- Enhancing Digital Marketing and E-Commerce Presence: Strengthening its digital marketing efforts and e-commerce platform can enable Lancer Orthodontics to reach a wider audience and improve customer engagement. This includes optimizing its website for search engines, leveraging social media marketing, and offering online ordering and support services. A strong online presence can enhance brand awareness, generate leads, and drive sales. The global e-commerce market is experiencing double-digit growth, creating opportunities for online sales expansion.
- Focus on Value-Added Services and Training: Offering value-added services, such as training programs and technical support, can differentiate Lancer Orthodontics from its competitors and enhance customer loyalty. Providing comprehensive training on its products and treatment techniques can help orthodontists and dentists achieve better clinical outcomes. These services can also generate additional revenue streams and strengthen customer relationships. The demand for continuing education and professional development in the dental industry is growing, presenting opportunities for value-added services.
What Are LANZ's Competitive Advantages?
- Established reputation since 1967.
- Comprehensive product range.
- Global customer base.
- Specialized focus on orthodontics.
What Does LANZ Do?
Lancer Orthodontics, Inc., established in 1967, specializes in the design, manufacture, and marketing of orthodontic products. Catering to orthodontists and dentists across the globe, Lancer Orthodontics offers a comprehensive portfolio of products essential for orthodontic treatment. These include aesthetic brackets, standard brackets and buccal tubes, bands, adhesives, wires, elastomerics, intraoral and extraoral appliances, instruments, and various other miscellaneous products. Based in Vista, California, the company has built a reputation for providing a wide array of orthodontic solutions. Lancer Orthodontics' extensive product line allows practitioners to source most, if not all, of their required materials from a single provider. This full-service approach has helped the company establish long-term relationships with its customer base. While the company's market capitalization is $0.00B, its continued operation since 1967 demonstrates its sustained presence in the orthodontic supplies market. Lancer Orthodontics focuses on delivering quality products and comprehensive solutions to meet the evolving needs of orthodontic professionals worldwide.
What Products and Services Does LANZ Offer?
- Designs and manufactures orthodontic products.
- Markets orthodontic products to orthodontists and dentists worldwide.
- Offers aesthetic brackets for improved appearance.
- Provides standard brackets and buccal tubes.
- Supplies bands, adhesives, and wires for orthodontic procedures.
- Offers elastomerics, intraoral, and extraoral appliances.
- Provides instruments and miscellaneous products for orthodontic practices.
How Does LANZ Make Money?
- Designs and manufactures a range of orthodontic products.
- Markets and sells these products directly to orthodontists and dentists.
- Generates revenue through product sales.
What Industry Does LANZ Operate In?
Lancer Orthodontics, Inc. operates within the medical instruments and supplies industry, a segment of the broader healthcare sector. This industry is characterized by technological advancements, stringent regulatory requirements, and increasing demand for innovative medical solutions. Lancer Orthodontics competes with both large, diversified medical device companies and smaller, specialized orthodontic suppliers. The company's success depends on its ability to offer high-quality products, maintain competitive pricing, and adapt to evolving market trends.
Who Are LANZ's Key Customers?
- Orthodontists
- Dental clinics
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 49 |
| 2026-08-26 | 49 |
| 2026-08-29 | 49 |
| 2026-09-01 | 49 |
| 2026-09-04 | 49 |
| 2026-09-07 | 49 |
| 2026-09-10 | 49 |
What changed?
The score has stayed at 49.
Over the same 18 days the stock moved +0.0%.
Key Financial Metrics
Return on equity for Lancer Orthodontics, Inc. stands at 0.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.7%, showing how much profit it generates from its asset base. LANZ trades at a trailing price-to-earnings ratio of 4.00, below the Healthcare sector average of ~21.50x. A current ratio of 5.41 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 30.6%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Lancer Orthodontics, Inc. operates in the Medical - Specialties industry within the Healthcare sector. It is headquartered in Vista, US. The company is led by CEO Joseph A. Irani. LANZ has traded publicly since 1993.
Financial Health
Lancer Orthodontics, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.78 places it in the distress zone, a signal of elevated financial risk.
Insider Activity
The most recent 12 insider filings for Lancer Orthodontics, Inc. break down as 5 sales and 7 purchases. On net that is roughly 305K shares acquired (about $137K) — insiders putting money in tends to read as conviction.
LANZ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Long-standing presence in the market since 1967.
- Comprehensive product range covering various orthodontic needs.
- Global customer base providing revenue diversification.
- Specialized focus on orthodontics, allowing for deep expertise.
Bear Case
- Small market capitalization of $0.00B, limiting access to capital.
- Low profit margin of 0.5%, indicating potential operational inefficiencies.
- OTC market listing, which may deter some institutional investors.
- Limited brand recognition compared to larger competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
LANZ Latest News
No recent news available for LANZ.
LANZ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for LANZ.
Price Targets
Wall Street price target analysis for LANZ.
LANZ MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for LANZ; grades run from A+ (80-100) to F (below 30).
Leadership: Cathy Wyss
CEO
Cathy Wyss serves as the CEO of Lancer Orthodontics, Inc., managing a workforce of 134 employees. As CEO, she is responsible for overseeing the company's strategic direction, operational efficiency, and financial performance. Her leadership is crucial in navigating the competitive landscape of the orthodontic supplies market and driving the company's growth initiatives.
Track Record: Due to limited information, Cathy Wyss's specific achievements and strategic decisions at Lancer Orthodontics, Inc. cannot be fully assessed. Further information is needed to evaluate her track record and contributions to the company's success.
LANZ OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Lancer Orthodontics, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it difficult for investors to assess their financial health and performance. Investing in OTC Other stocks carries a higher degree of risk compared to stocks listed on major exchanges like the NYSE or NASDAQ due to the lack of regulatory oversight and transparency.
- OTC Tier: OTC Other
- Limited financial disclosure, making it difficult to assess the company's financial health.
- Lower trading volume and wider bid-ask spreads, leading to potential price volatility.
- Lack of regulatory oversight compared to major exchanges.
- Potential for fraud or manipulation due to limited transparency.
- Higher risk of delisting or going out of business.
- Verify the company's registration and legal status.
- Obtain and review any available financial statements.
- Assess the company's management team and track record.
- Research the company's products, services, and market position.
- Evaluate the company's competitive landscape and potential risks.
- Understand the OTC market and its associated risks.
- Consult with a financial advisor before investing.
- Long-standing presence in the market since 1967.
- Comprehensive product range catering to orthodontic needs.
- Global customer base indicating market acceptance.
- Physical headquarters in Vista, California.
Lancer Orthodontics, Inc. Healthcare Stock: Key Questions Answered
Is LANZ a good stock?
Stock Expert AI does not rate LANZ buy, sell or hold. Lancer Orthodontics, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about LANZ stock?
As of 2026-03-18, there is no readily available analyst coverage or consensus on Lancer Orthodontics, Inc. (LANZ) due to its OTC listing and small market capitalization. Investors should conduct their own thorough research and due diligence before making any investment decisions.
What are the key factors to evaluate for LANZ?
Evaluate LANZ on fundamentals, analyst consensus, and risk factors. P/E: 4.00x vs the S&P 500's ~20-25x. Lancer Orthodontics, Inc. presents a focused investment case centered on its established position in the orthodontic supplies market. Not financial advice.
How frequently does LANZ data refresh on this page?
LANZ's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 calculations are scheduled daily at 10:15 UTC; the score's own date shows its last successful run.
What has driven LANZ's recent stock price performance?
Lancer Orthodontics, Inc. (LANZ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Long-standing presence in the market since 1967. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LANZ overvalued or undervalued right now?
Lancer Orthodontics, Inc. (LANZ) trades at 4.00x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of LANZ?
Yes, most major brokerages offer fractional shares of Lancer Orthodontics, Inc. (LANZ) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track LANZ's earnings and financial reports?
Lancer Orthodontics, Inc. (LANZ) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for LANZ earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available on the company due to its OTC listing and small market capitalization.
- Analyst coverage and consensus are not available.
- Financial data may not be readily accessible or up-to-date.